Difference between revisions of "Team:Hannover/Reference"
m |
|||
| Line 64: | Line 64: | ||
<li>Boch, J. (2011). TALEs of genome targeting. Nature Biotechnology , 29 (2), pp. 135-136.</li> | <li>Boch, J. (2011). TALEs of genome targeting. Nature Biotechnology , 29 (2), pp. 135-136.</li> | ||
| − | <li>Boch, J. | + | <li>Boch, J. et al. (2009). Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science (326), pp. 1509-1512.</li> |
| − | <li>Boch, J., | + | <li>Boch, J., et al. (2009). Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science (326), pp. 1509-1512.</li> |
<li>Camarero, J. A., Fushman, D., Cowburn, D., & Muir, T. W. (2001). Peptide Chemical Ligation Inside Living Cells: In Vivo Generation of a Circular Protein Domain. Bioorganic & Medicinal Chemistry , pp. 2479-2484.</li> | <li>Camarero, J. A., Fushman, D., Cowburn, D., & Muir, T. W. (2001). Peptide Chemical Ligation Inside Living Cells: In Vivo Generation of a Circular Protein Domain. Bioorganic & Medicinal Chemistry , pp. 2479-2484.</li> | ||
| Line 74: | Line 74: | ||
<li>Evans, T. C., Benner, J., & Xu, M.-Q. (1999). The Cyclization and Polymerisation of Bacterially Expressed Proteins Using Modified Self-splicing Inteins. The Journal of Biological Chemistry , 274 (26), pp. 18359-18363.</li> | <li>Evans, T. C., Benner, J., & Xu, M.-Q. (1999). The Cyclization and Polymerisation of Bacterially Expressed Proteins Using Modified Self-splicing Inteins. The Journal of Biological Chemistry , 274 (26), pp. 18359-18363.</li> | ||
| − | <li>Geissler, R. | + | <li>Geissler, R. et al. (2011). Transcriptional Activators of Human Genes with Programmable DNA-Specificity. PLOS one.</li> |
| − | + | ||
| − | + | ||
<li>Hirschler, B. (2016, May). Second baby gets Cellectis "designer" cells to clear leukemia. Retrieved 10 13, 2016, from Reuters: http://www.reuters.com/article/us-health-celltherapy-idUSKCN0XX1F7</li> | <li>Hirschler, B. (2016, May). Second baby gets Cellectis "designer" cells to clear leukemia. Retrieved 10 13, 2016, from Reuters: http://www.reuters.com/article/us-health-celltherapy-idUSKCN0XX1F7</li> | ||
| Line 82: | Line 80: | ||
<li>Iwai, H., Lingel, A., & Plückthun, A. (2001). Cyclic Green Fluorescent Protein Produced in Vivo Using an Artificially Split PI-PfuI Intein from Pyrococcus furiosus. The Journal of Biological Chemistry , 276 (19), pp. 16548-16554.</li> | <li>Iwai, H., Lingel, A., & Plückthun, A. (2001). Cyclic Green Fluorescent Protein Produced in Vivo Using an Artificially Split PI-PfuI Intein from Pyrococcus furiosus. The Journal of Biological Chemistry , 276 (19), pp. 16548-16554.</li> | ||
| − | <li>Lonzaric, J. | + | <li>iGEM Team Heidelberg (2014). The Ring of Fire. Retrieved 10 13, 2016, from CIRCULARIZATION - Transforming an enzyme into a ring of fire: https://2014.igem.org/Team:Heidelberg/Toolbox/Circularization</li> |
| + | |||
| + | <li>Lonzaric, J. et al. (2016). Locked and proteolysis-based transcription activator-like effector (TALE) regulation. Nucleic Acids Research , 44 (3), pp. 1471-1481.</li> | ||
| − | <li>Miller, J. | + | <li>Miller, J. et al. (2011). A TALE nuclease architecture for efficient genome editing. Nature Biotechnology , 29 (2), pp. 143-148.</li> |
<li>Muir, T. W. (2003). Semisynthesis of proteins by expressed protein ligation. Annu. Rev. Biochem. (72), pp. 249-289.</li> | <li>Muir, T. W. (2003). Semisynthesis of proteins by expressed protein ligation. Annu. Rev. Biochem. (72), pp. 249-289.</li> | ||
| Line 90: | Line 90: | ||
<li>Office, G.-I. P. (2015, September). World first use of gene-edited immune cells to treat ‘incurable’ leukemia. Retrieved 10 13, 2016, from Great Ormond Street Hospital for Children: http://www.gosh.nhs.uk/news/press-releases/2015-press-release-archive/world-first-use-gene-edited-immune-cells-treat-incurable-leukaemia</li> | <li>Office, G.-I. P. (2015, September). World first use of gene-edited immune cells to treat ‘incurable’ leukemia. Retrieved 10 13, 2016, from Great Ormond Street Hospital for Children: http://www.gosh.nhs.uk/news/press-releases/2015-press-release-archive/world-first-use-gene-edited-immune-cells-treat-incurable-leukaemia</li> | ||
| − | <li>Qasim, W. | + | <li>Qasim, W. et al. (2015). First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL. Blood , 126 (23), p. 2046.</li> |
<li>Specter, M. (2016, August). How the DNA Revolution Is Changing Us. Retrieved 10 13, 2016, from National Geographic: http://www.nationalgeographic.com/magazine/2016/08/dna-crispr-gene-editing-science-ethics/</li> | <li>Specter, M. (2016, August). How the DNA Revolution Is Changing Us. Retrieved 10 13, 2016, from National Geographic: http://www.nationalgeographic.com/magazine/2016/08/dna-crispr-gene-editing-science-ethics/</li> | ||
| − | <li>Streubel, J. | + | <li>Streubel, J. et al. (2013). TALEs - Proteine mit programmierbarer DNA-Bindespezifität. BIOspektrum , 2013 (4), pp. 370-373.</li> |
<li>Tavassoli, A., & Benkovic, S. J. (2007). Split-intein mediated circular ligation use in the synthesis of cyclic peptide libraries in E. coli. Nature Protocols , 2 (5), pp. 1126-1133.</li> | <li>Tavassoli, A., & Benkovic, S. J. (2007). Split-intein mediated circular ligation use in the synthesis of cyclic peptide libraries in E. coli. Nature Protocols , 2 (5), pp. 1126-1133.</li> | ||
| − | <li>Weber, E. | + | <li>Weber, E. et al. (2011). Assembly of Designer TAL Effectors by Golden Gate Cloning. PloS One , 6 (5).</li> |
<li>Williams, N. K. (2002). In Vivo Protein Cyclization Promoted by a Circularly Permuted Synechocystis sp. PCC6803 DnaB Mini-intein. The Journal of Biological Chemistry , 227 (10), pp. 7790-7798.</li> | <li>Williams, N. K. (2002). In Vivo Protein Cyclization Promoted by a Circularly Permuted Synechocystis sp. PCC6803 DnaB Mini-intein. The Journal of Biological Chemistry , 227 (10), pp. 7790-7798.</li> | ||
Revision as of 17:19, 19 October 2016
References
- Boch, J. (2011). TALEs of genome targeting. Nature Biotechnology , 29 (2), pp. 135-136.
- Boch, J. et al. (2009). Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science (326), pp. 1509-1512.
- Boch, J., et al. (2009). Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science (326), pp. 1509-1512.
- Camarero, J. A., Fushman, D., Cowburn, D., & Muir, T. W. (2001). Peptide Chemical Ligation Inside Living Cells: In Vivo Generation of a Circular Protein Domain. Bioorganic & Medicinal Chemistry , pp. 2479-2484.
- Camarero, J. A., Fushman, D., Cowburn, D., & Muir, T. W. (2001). Peptide Chemical Ligation Inside Living Cells: In Vivo Generation of a Circular Protein Domain. Bioorganic & Medicinal Chemistry , pp. 2479-2484.
- Evans, T. C., Benner, J., & Xu, M.-Q. (1999). The Cyclization and Polymerisation of Bacterially Expressed Proteins Using Modified Self-splicing Inteins. The Journal of Biological Chemistry , 274 (26), pp. 18359-18363.
- Geissler, R. et al. (2011). Transcriptional Activators of Human Genes with Programmable DNA-Specificity. PLOS one.
- Hirschler, B. (2016, May). Second baby gets Cellectis "designer" cells to clear leukemia. Retrieved 10 13, 2016, from Reuters: http://www.reuters.com/article/us-health-celltherapy-idUSKCN0XX1F7
- Iwai, H., Lingel, A., & Plückthun, A. (2001). Cyclic Green Fluorescent Protein Produced in Vivo Using an Artificially Split PI-PfuI Intein from Pyrococcus furiosus. The Journal of Biological Chemistry , 276 (19), pp. 16548-16554.
- iGEM Team Heidelberg (2014). The Ring of Fire. Retrieved 10 13, 2016, from CIRCULARIZATION - Transforming an enzyme into a ring of fire: https://2014.igem.org/Team:Heidelberg/Toolbox/Circularization
- Lonzaric, J. et al. (2016). Locked and proteolysis-based transcription activator-like effector (TALE) regulation. Nucleic Acids Research , 44 (3), pp. 1471-1481.
- Miller, J. et al. (2011). A TALE nuclease architecture for efficient genome editing. Nature Biotechnology , 29 (2), pp. 143-148.
- Muir, T. W. (2003). Semisynthesis of proteins by expressed protein ligation. Annu. Rev. Biochem. (72), pp. 249-289.
- Office, G.-I. P. (2015, September). World first use of gene-edited immune cells to treat ‘incurable’ leukemia. Retrieved 10 13, 2016, from Great Ormond Street Hospital for Children: http://www.gosh.nhs.uk/news/press-releases/2015-press-release-archive/world-first-use-gene-edited-immune-cells-treat-incurable-leukaemia
- Qasim, W. et al. (2015). First Clinical Application of Talen Engineered Universal CAR19 T Cells in B-ALL. Blood , 126 (23), p. 2046.
- Specter, M. (2016, August). How the DNA Revolution Is Changing Us. Retrieved 10 13, 2016, from National Geographic: http://www.nationalgeographic.com/magazine/2016/08/dna-crispr-gene-editing-science-ethics/
- Streubel, J. et al. (2013). TALEs - Proteine mit programmierbarer DNA-Bindespezifität. BIOspektrum , 2013 (4), pp. 370-373.
- Tavassoli, A., & Benkovic, S. J. (2007). Split-intein mediated circular ligation use in the synthesis of cyclic peptide libraries in E. coli. Nature Protocols , 2 (5), pp. 1126-1133.
- Weber, E. et al. (2011). Assembly of Designer TAL Effectors by Golden Gate Cloning. PloS One , 6 (5).
- Williams, N. K. (2002). In Vivo Protein Cyclization Promoted by a Circularly Permuted Synechocystis sp. PCC6803 DnaB Mini-intein. The Journal of Biological Chemistry , 227 (10), pp. 7790-7798.
- Wood, D. W., & Camarero, J. A. (2014). Intein Applications: From Protein Purification and Labeling to Metabolic Control Methods. The Journal of Biological Chemistry , 289 (21), pp. 14512-14519.
